December 2012). "Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in ... some to suggest that cutaneous melanin might somehow serve to protect the neuromelanin in substantia nigra from external toxins ... vivo". Cutaneous and Ocular Toxicology. 31 (4): 312-7. doi:10.3109/15569527.2012.676119. PMID 22515841. S2CID 30344869. King G ...

Shaw, LA (1928). "Cutaneous Respiration of the Cat". American Journal of Physiology. 85 (1): 158-67. doi:10.1152/ajplegacy. ... A Design for Small Children and Infants with an Appliance for the Administration of Oxygen and Carbon Dioxide". J Clin Invest. ... Shaw, LA; Drinker, P (1929). "AN APPARATUS FOR THE PROLONGED ADMINISTRATION OF ARTIFICIAL RESPIRATION: I. A Design for Adults ... Drinker, P; Shaw, LA (1932). "The prolonged administration of artificial respiration". Journal of the Franklin Institute. 213 ( ...

"国家食品药品监督管理总局关于停止生产销售使用酮康唑口服制剂的公告（2015年第85号）" (in Chinese). China Food and Drug Administration. 25 June 2015. Archived from the ... Gupta AK, Lyons DC (2015). "The Rise and Fall of Oral Ketoconazole". Journal of Cutaneous Medicine and Surgery. 19 (4): 352-7. ... Applied to the skin it is used for fungal skin infections such as tinea, cutaneous candidiasis, pityriasis versicolor, dandruff ... U.S. Food and Drug Administration. 26 July 2013. Archived from

The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. On 13 October 2022, the Committee for ... Journal of Cutaneous Medicine and Surgery. 24 (2): 199-200. doi:10.1177/1203475419888862. PMID 32208020. S2CID 214641620. "Drug ... "Advancing Health Through Innovation: New Drug Therapy Approvals 2022". U.S. Food and Drug Administration (FDA). 10 January 2023 ... Approval Package: Spevigo". U.S. Food and Drug Administration (FDA). Archived from the original on 26 December 2022. Retrieved ...

Recent research[citation needed] has suggested a role for retinoids in cutaneous adverse effects for a variety of drugs ... "Drug Approval Package: Aklief". US Food and Drug Administration. October 21, 2019. Archived from the original on 19 November ... Journal of Cutaneous Medicine and Surgery. SAGE Publications. 26 (1): 71-78. doi:10.1177/12034754211035091. ISSN 1203-4754. PMC ...

SJS and TEN most often begin between 4 and 28 days after culprit drug administration. A published algorithm (ALDEN) to assess ... All three are part of a spectrum of severe cutaneous reactions (SCAR) which affect skin and mucous membranes. The distinction ... Severe Cutaneous Adverse Reactions (2002). "Correlations between clinical patterns and causes of Erythema Multiforme Majus, ... Su SC, Hung SI, Fan WL, Dao RL, Chung WH (2016). "Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to ...

Tissue and systemic diffusion of idrocilamide after cutaneous administration]". Revue du Rhumatisme (in French). 60 (12): 932-6 ...

In September 2018, it was approved by the U.S. Food and Drug Administration (FDA) for treating people with metastatic cutaneous ... "FDA approves first treatment for advanced form of the second most common skin cancer". U.S. Food and Drug Administration. 28 ... New PD-1 Inhibitor OK'd for Cutaneous SCC - Sixth PD-1/PD-L1 checkpoint inhibitor approved by agency 2018 "FDA approves ... Lee A, Duggan S, Deeks ED (June 2020). "Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma". Drugs. 80 (8): 813 ...

Infection caused by cutaneous larvae migrans, a skin disease in humans, is characterized by skin ruptures and severe itching. ... "Clinical Aspects and Treatment of the More Common Intestinal Parasites of Man (TB-33)". Veterans Administration Technical ... Cryotherapy by application of liquid nitrogen to the skin has been used to kill cutaneous larvae migrans, but the procedure has ... Caumes, Eric (2000). "Treatment of Cutaneous Larva Migrans". Clin Infect Dis. 30 (5): 811-814. doi:10.1086/313787. PMID ...

medicine portal List of cutaneous conditions Steroid acne Freedberg, et al. (2003). Fitzpatrick's Dermatology in General ... Steroid folliculitis occurs following administration of glucocorticoids or corticotropin. Other medications can also mimic ...

Alternatives to oral administration have been studied.[citation needed] Terbinafine may induce or exacerbate subacute cutaneous ... The U.S. Food and Drug Administration has approved the first generic versions of prescription Lamisil (terbinafine ... Callen JP, Hughes AP, Kulp-Shorten C (September 2001). "Subacute cutaneous lupus erythematosus induced or exacerbated by ... "PI and CMI Trade Names and Active Ingredients containing Terbinafine". Therapeutic Goods Administration. Australian Government ...

In June 2018, it was approved for the treatment of certain melanomas by the U.S. Food and Drug Administration (FDA) in ... Koelblinger P, Dornbierer J, Dummer R (August 2017). "A review of binimetinib for the treatment of mutant cutaneous melanoma". ... "Drug Trial Snapshot: Mektovi". U.S. Food and Drug Administration (FDA). 19 December 2019. Archived from the original on 19 ... In October 2023, the US Food and Drug Administration approved encorafenib with binimetinib for adults with metastatic non-small ...

Additionally the administration of more dose intensive epirubicin-containing regimens to patients with metastatic breast cancer ... Reversible alopecia and local cutaneous reactions are important adverse effects too. Those could be related with radiation ... are 1.3 to 1.7 times higher for doxorubicin than epirubicin following single-dose intravenous administration. Epirubicin shows ... of patients without a right prophylactic antiemetics therapy experience nausea and vomiting the first 24 h after administration ...

Food and Drug Administration granted orphan drug designation for naloxone lotion as a treatment for pruritus in cutaneous T- ... Cutaneous B-cell lymphoma List of cutaneous conditions "Cutaneous T-Cell Lymphoma: Practice Essentials, Background, ... Cutaneous T-cell lymphoma (CTCL) is a class of non-Hodgkin lymphoma, which is a type of cancer of the immune system. Unlike ... Cutaneous T-cell lymphoma may be divided into the several subtypes.: 727-740 Mycosis fungoides is the most common form of CTCL ...

From 1962 to 1964 he was a resident in dermatology and syphilology at the Bronx Veterans Administration Hospital in New York. ... 1990 American College of Mohs Micrographic Surgery and Cutaneous Oncology: Board Certification. In 1978 Perry founded the Skin ...

However, priority was given to the development of the compound for cutaneous metastases of breast cancer. In 1992 a new ... "FDA approves Impavido to treat tropical disease leishmaniasis". U.S. Food and Drug Administration (FDA) (Press release). 19 ... This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal. It may be used with liposomal amphotericin B ... Miltefosine is primarily used for the treatment of visceral and New World cutaneous leishmaniasis, and is undergoing clinical ...

List of cutaneous conditions McKnight JT, Maxwell AJ, Anderson RL (1992). "Warfarin necrosis". Arch Fam Med. 1 (1): 105-8. doi: ... These include gradual increase starting from low doses and supplemental administration of protein C (pure or from fresh frozen ... Since the clot-promoting effects of starting administration of 4-hydroxycoumarins are transitory, patients with protein C ...

It shortens the course of cutaneous disease and may protect against its dissemination. Varicella zoster virus is a human herpes ... This medication is not recommended for administration to immune-competent persons for the treatment of active disease. The ...

Even with proper administration of vitamin K, people can still have the serious reactions mentioned above. Vitamin K may be ... Zhang M, Chen J, Wang CX, Lin NX, Li X (October 2022). "Cutaneous allergic reaction to subcutaneous vitamin K1: A case report ... Intravenous administration of vitamin K should only be done by a healthcare facility under the care of a healthcare ... Vitamin K that is injected is available as a glass ampule, so a filter should be used prior to administration to avoid glass ...

Food and Drug Administration (FDA) therapy for cutaneous T-cell lymphoma. Evidence suggests that this treatment might help ... "Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results". New England Journal of ...

In 1999, Ontak was approved by the U.S. Food and Drug Administration (FDA) for treatment of Cutaneous T-cell lymphoma (CTCL). ... "FDA Drug Shortages". U.S. Food and Drug Administration. 31 January 2014. Retrieved 3 July 2017. FDA Safety Alert v t e ( ... "Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma". Cancer Management and ...

AK with cutaneous horn: A cutaneous horn is a keratinic projection with its height at least one-half of its diameter, often ... "Klisyri: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 15 December 2020. "NDA APPROVAL" (PDF). U.S. ... 38-40% of cutaneous horns represent AKs. Pigmented AK: Pigmented AKs are rare variants that often present as macules or plaques ... Kim JY, Kozlow JH, Mittal B, Moyer J, Olenecki T, Rodgers P (March 2018). "Guidelines of care for the management of cutaneous ...

Fåhraeus L, Larsson-Cohn U (December 1982). "Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of ... With oral administration of estradiol, the ratio of estradiol levels to estrone levels is about 5 times higher on average than ... Oral administration of menopausal replacement dosages of estradiol results in low, follicular phase levels of estradiol, ... Selby P, McGarrigle HH, Peacock M (March 1989). "Comparison of the effects of oral and transdermal oestradiol administration on ...

Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration ...

In September 2022, the U.S. Food and Drug Administration (FDA) approved sodium thiosulfate under the brand name Pedmark to ... "Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature". American ... Food and Drug Administration. 20 September 2022. Archived from the original on 9 March 2023. Retrieved 9 March 2023. Auriemma M ...

Fåhraeus L, Larsson-Cohn U (December 1982). "Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of ... With oral administration of estradiol, the ratio of estradiol levels to estrone levels is about 5 times higher on average than ... Oral administration of menopausal replacement dosages of estradiol results in low, follicular phase levels of estradiol, ... In these studies, prior to administration of estrone, amenorrhea, atrophy of the breasts (as well as flaccidity and small and ...

"Table of Pharmacogenomic Biomarkers in Drug Labels". U.S. Food and Drug Administration. "Tumor Markers Fact Sheet" (PDF). ... "Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome". American ...

Approved usage: Vorinostat was licensed by the U.S. FDA in October 2006 for the treatment of cutaneous T cell lymphoma (CTCL). ... Full Prescribing Information" (PDF). Food and Drug Administration (FDA). Archived from the original (PDF) on 20 January 2022. ... Full prescribing information" (PDF). Food and Drug Administration (FDA). Archived from the original (PDF) on 25 January 2022. ... Romidepsin (trade name Istodax) was licensed by the US FDA in Nov 2009 for cutaneous T-cell lymphoma (CTCL). Phase III Clinical ...

The routes of administration vary. They may be both systemic and topical. For example, pseudoephedrine is taken orally and ... Cutaneous vasoconstriction will occur because of the body's exposure to the severe cold. Examples of endogenous factors include ...

On occasion,[which?] serum levels of the drug can be identified from oral, vaginal, or cutaneous administration, and lead to ...